What’s more, Guzzardi et al. [50] suggested that patients with alpha-1 antitrypsin (A1AT) deficiency and longstanding FQ use (26 months) may have a higher risk of AAD. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.